Advancements in non-invasive biomarkers for detection and monitoring of breast cancer recurrence

A narrative review discusses emerging non-invasive biomarkers—including circulating tumor DNA, circulating tumor cells, exosomes, and multi-omics approaches—that enable earlier molecular relapse detection, dynamic treatment monitoring, and personalized intervention.